APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics Platforms for Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Therapeutics Platforms for Mental Health Market Analysis and Forecast 2026-2032

Report ID 17411894026 March 2026215 pages

Choose your research edition.

Industry ResearchDigital Therapeutics Platforms for Mental Health Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics Platforms for Mental Health Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics Platforms for Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics Platforms for Mental Health Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics Platforms for Mental Health Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Digital Therapeutics Platforms for Mental Health market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Therapeutics Platforms for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Therapeutics Platforms for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Therapeutics Platforms for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Therapeutics Platforms for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Therapeutics Platforms for Mental Health include Akili Interactive, Teladoc Health, Talkspace, CogniFit, Orexo, SilverCloud (Amwell), Noom, Big Health and Cognoa, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Therapeutics Platforms for Mental Health, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Therapeutics Platforms for Mental Health, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Therapeutics Platforms for Mental Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Therapeutics Platforms for Mental Health revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Therapeutics Platforms for Mental Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Therapeutics Platforms for Mental Health revenue, projected growth trends, production technology, application and end-user industry.

Digital Therapeutics Platforms for Mental Health Segment by Company

Akili Interactive

Teladoc Health

Talkspace

CogniFit

Orexo

SilverCloud (Amwell)

Noom

Big Health

Cognoa

Headspace Health

Calm Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Woebot Health

LifeStance Health

Cerebral

MoodMission

Youper

Best Covered

Dami and Xiaomi

WeiMai

Digital Therapeutics Platforms for Mental Health Segment by Type

Apps

Online Platforms

Digital Therapeutics Platforms for Mental Health Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms for Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms for Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms for Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms for Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Therapeutics Platforms for Mental Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Therapeutics Platforms for Mental Health company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Therapeutics Platforms for Mental Health revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Therapeutics Platforms for Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Apps Major Player Table 3. Online Platforms Major Player Table 4. Global Digital Therapeutics Platforms for Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Enterprise Major Player Table 6. Personal Major Player Table 7. Digital Therapeutics Platforms for Mental Health Industry Trends Table 8. Digital Therapeutics Platforms for Mental Health Industry Drivers Table 9. Digital Therapeutics Platforms for Mental Health Industry Opportunities and Challenges Table 10. Digital Therapeutics Platforms for Mental Health Industry Restraints Table 11. Global Digital Therapeutics Platforms for Mental Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Digital Therapeutics Platforms for Mental Health Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Digital Therapeutics Platforms for Mental Health Market Share by Region (2021-2026) Table 14. Global Digital Therapeutics Platforms for Mental Health Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Digital Therapeutics Platforms for Mental Health Market Share by Region (2027-2032) Table 16. Global Digital Therapeutics Platforms for Mental Health Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Players (2021-2026) Table 18. Global Digital Therapeutics Platforms for Mental Health Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Digital Therapeutics Platforms for Mental Health Key Players Headquarters & Area Served Table 20. Global Digital Therapeutics Platforms for Mental Health Players, Product Type & Application Table 21. Global Digital Therapeutics Platforms for Mental Health Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Digital Therapeutics Platforms for Mental Health by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Digital Therapeutics Platforms for Mental Health Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Type (2021-2026) Table 28. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Type (2027-2032) Table 29. Global Digital Therapeutics Platforms for Mental Health Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Application (2021-2026) Table 33. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Application (2027-2032) Table 34. Akili Interactive Company Information Table 35. Akili Interactive Business Overview Table 36. Akili Interactive Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Akili Interactive Digital Therapeutics Platforms for Mental Health Product Portfolio Table 38. Akili Interactive Recent Development Table 39. Teladoc Health Company Information Table 40. Teladoc Health Business Overview Table 41. Teladoc Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teladoc Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 43. Teladoc Health Recent Development Table 44. Talkspace Company Information Table 45. Talkspace Business Overview Table 46. Talkspace Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Talkspace Digital Therapeutics Platforms for Mental Health Product Portfolio Table 48. Talkspace Recent Development Table 49. CogniFit Company Information Table 50. CogniFit Business Overview Table 51. CogniFit Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. CogniFit Digital Therapeutics Platforms for Mental Health Product Portfolio Table 53. CogniFit Recent Development Table 54. Orexo Company Information Table 55. Orexo Business Overview Table 56. Orexo Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Orexo Digital Therapeutics Platforms for Mental Health Product Portfolio Table 58. Orexo Recent Development Table 59. SilverCloud (Amwell) Company Information Table 60. SilverCloud (Amwell) Business Overview Table 61. SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Product Portfolio Table 63. SilverCloud (Amwell) Recent Development Table 64. Noom Company Information Table 65. Noom Business Overview Table 66. Noom Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Noom Digital Therapeutics Platforms for Mental Health Product Portfolio Table 68. Noom Recent Development Table 69. Big Health Company Information Table 70. Big Health Business Overview Table 71. Big Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Big Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 73. Big Health Recent Development Table 74. Cognoa Company Information Table 75. Cognoa Business Overview Table 76. Cognoa Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Cognoa Digital Therapeutics Platforms for Mental Health Product Portfolio Table 78. Cognoa Recent Development Table 79. Headspace Health Company Information Table 80. Headspace Health Business Overview Table 81. Headspace Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Headspace Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 83. Headspace Health Recent Development Table 84. Calm Health Company Information Table 85. Calm Health Business Overview Table 86. Calm Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Calm Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 88. Calm Health Recent Development Table 89. Lark Health Company Information Table 90. Lark Health Business Overview Table 91. Lark Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Lark Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 93. Lark Health Recent Development Table 94. Vida Health Company Information Table 95. Vida Health Business Overview Table 96. Vida Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Vida Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 98. Vida Health Recent Development Table 99. Mahana Therapeutics Company Information Table 100. Mahana Therapeutics Business Overview Table 101. Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio Table 103. Mahana Therapeutics Recent Development Table 104. Blue Note Therapeutics Company Information Table 105. Blue Note Therapeutics Business Overview Table 106. Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio Table 108. Blue Note Therapeutics Recent Development Table 109. Lyra Health Company Information Table 110. Lyra Health Business Overview Table 111. Lyra Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Lyra Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 113. Lyra Health Recent Development Table 114. Modern Health Company Information Table 115. Modern Health Business Overview Table 116. Modern Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Modern Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 118. Modern Health Recent Development Table 119. Canary Health Company Information Table 120. Canary Health Business Overview Table 121. Canary Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Canary Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 123. Canary Health Recent Development Table 124. Woebot Health Company Information Table 125. Woebot Health Business Overview Table 126. Woebot Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Woebot Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 128. Woebot Health Recent Development Table 129. LifeStance Health Company Information Table 130. LifeStance Health Business Overview Table 131. LifeStance Health Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. LifeStance Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 133. LifeStance Health Recent Development Table 134. Cerebral Company Information Table 135. Cerebral Business Overview Table 136. Cerebral Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Cerebral Digital Therapeutics Platforms for Mental Health Product Portfolio Table 138. Cerebral Recent Development Table 139. MoodMission Company Information Table 140. MoodMission Business Overview Table 141. MoodMission Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. MoodMission Digital Therapeutics Platforms for Mental Health Product Portfolio Table 143. MoodMission Recent Development Table 144. Youper Company Information Table 145. Youper Business Overview Table 146. Youper Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Youper Digital Therapeutics Platforms for Mental Health Product Portfolio Table 148. Youper Recent Development Table 149. Best Covered Company Information Table 150. Best Covered Business Overview Table 151. Best Covered Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Best Covered Digital Therapeutics Platforms for Mental Health Product Portfolio Table 153. Best Covered Recent Development Table 154. Dami and Xiaomi Company Information Table 155. Dami and Xiaomi Business Overview Table 156. Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Product Portfolio Table 158. Dami and Xiaomi Recent Development Table 159. WeiMai Company Information Table 160. WeiMai Business Overview Table 161. WeiMai Digital Therapeutics Platforms for Mental Health Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. WeiMai Digital Therapeutics Platforms for Mental Health Product Portfolio Table 163. WeiMai Recent Development Table 164. North America Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 165. North America Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 166. North America Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 167. North America Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 168. North America Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. North America Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 170. North America Digital Therapeutics Platforms for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 171. Europe Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 174. Europe Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 175. Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 177. Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 178. China Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 179. China Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 180. China Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 181. China Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Digital Therapeutics Platforms for Mental Health Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Digital Therapeutics Platforms for Mental Health Revenue by Region (US$ Million) & (2021-2026) Table 188. Asia Digital Therapeutics Platforms for Mental Health Revenue by Region (US$ Million) & (2027-2032) Table 189. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 195. SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Digital Therapeutics Platforms for Mental Health Image Figure 2. Global Digital Therapeutics Platforms for Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics Platforms for Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 4. Apps Image Figure 5. Online Platforms Image Figure 6. Global Digital Therapeutics Platforms for Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Digital Therapeutics Platforms for Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 8. Enterprise Image Figure 9. Personal Image Figure 10. Global Digital Therapeutics Platforms for Mental Health Market Size (US$ Million) & (2021-2032) Figure 11. Global Digital Therapeutics Platforms for Mental Health Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Digital Therapeutics Platforms for Mental Health Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Digital Therapeutics Platforms for Mental Health Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Digital Therapeutics Platforms for Mental Health Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Type (2021-2032) Figure 18. Global Digital Therapeutics Platforms for Mental Health Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Application (2021-2032) Figure 21. North America Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032) Figure 23. North America Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032) Figure 24. North America Digital Therapeutics Platforms for Mental Health Revenue Share by Country (2021-2032) Figure 25. United States Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032) Figure 30. Europe Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032) Figure 31. Europe Digital Therapeutics Platforms for Mental Health Revenue Share by Country (2021-2032) Figure 32. Germany Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032) Figure 42. China Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032) Figure 43. Asia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032) Figure 45. Asia Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032) Figure 46. Asia Digital Therapeutics Platforms for Mental Health Revenue Share by Region (2021-2032) Figure 47. Japan Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032) Figure 55. SAMEA Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032) Figure 56. SAMEA Digital Therapeutics Platforms for Mental Health Revenue Share by Country (2021-2032) Figure 57. Brazil Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Digital Therapeutics Platforms for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Apps
  • Online Platforms
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • Teladoc Health
  • Talkspace
  • CogniFit
  • Orexo
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Cognoa
  • Headspace Health
  • Calm Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Woebot Health
  • LifeStance Health
  • Cerebral
  • MoodMission
  • Youper
  • Best Covered
  • Dami and Xiaomi
  • WeiMai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Therapeutics Platforms for Mental Health Market by Type
  3. 1.2.1 Global Digital Therapeutics Platforms for Mental Health Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Apps
  5. 1.2.3 Online Platforms
  6. 1.3 Digital Therapeutics Platforms for Mental Health Market by Application
  7. 1.3.1 Global Digital Therapeutics Platforms for Mental Health Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Enterprise
  9. 1.3.3 Personal
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Digital Therapeutics Platforms for Mental Health Market Dynamics
  1. 2.1 Digital Therapeutics Platforms for Mental Health Industry Trends
  2. 2.2 Digital Therapeutics Platforms for Mental Health Industry Drivers
  3. 2.3 Digital Therapeutics Platforms for Mental Health Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics Platforms for Mental Health Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Therapeutics Platforms for Mental Health Market Perspective (2021-2032)
  2. 3.2 Global Digital Therapeutics Platforms for Mental Health Growth Trends by Region
  3. 3.2.1 Global Digital Therapeutics Platforms for Mental Health Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Therapeutics Platforms for Mental Health Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Therapeutics Platforms for Mental Health Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Therapeutics Platforms for Mental Health Revenue by Players
  2. 4.1.1 Global Digital Therapeutics Platforms for Mental Health Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Therapeutics Platforms for Mental Health Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Therapeutics Platforms for Mental Health Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Therapeutics Platforms for Mental Health Key Players Headquarters & Area Served
  7. 4.4 Global Digital Therapeutics Platforms for Mental Health Players, Product Type & Application
  8. 4.5 Global Digital Therapeutics Platforms for Mental Health Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Therapeutics Platforms for Mental Health Market CR5 and HHI
  11. 4.6.3 2025 Digital Therapeutics Platforms for Mental Health Tier 1, Tier 2, and Tier 3
5 Digital Therapeutics Platforms for Mental Health Market Size by Type
  1. 5.1 Global Digital Therapeutics Platforms for Mental Health Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 5.3 Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Type (2021-2032)
6 Digital Therapeutics Platforms for Mental Health Market Size by Application
  1. 6.1 Global Digital Therapeutics Platforms for Mental Health Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  3. 6.3 Global Digital Therapeutics Platforms for Mental Health Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Akili Interactive
  2. 7.1.1 Akili Interactive Company Information
  3. 7.1.2 Akili Interactive Business Overview
  4. 7.1.3 Akili Interactive Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Akili Interactive Digital Therapeutics Platforms for Mental Health Product Portfolio
  6. 7.1.5 Akili Interactive Recent Developments
  7. 7.2 Teladoc Health
  8. 7.2.1 Teladoc Health Company Information
  9. 7.2.2 Teladoc Health Business Overview
  10. 7.2.3 Teladoc Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teladoc Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  12. 7.2.5 Teladoc Health Recent Developments
  13. 7.3 Talkspace
  14. 7.3.1 Talkspace Company Information
  15. 7.3.2 Talkspace Business Overview
  16. 7.3.3 Talkspace Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Talkspace Digital Therapeutics Platforms for Mental Health Product Portfolio
  18. 7.3.5 Talkspace Recent Developments
  19. 7.4 CogniFit
  20. 7.4.1 CogniFit Company Information
  21. 7.4.2 CogniFit Business Overview
  22. 7.4.3 CogniFit Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CogniFit Digital Therapeutics Platforms for Mental Health Product Portfolio
  24. 7.4.5 CogniFit Recent Developments
  25. 7.5 Orexo
  26. 7.5.1 Orexo Company Information
  27. 7.5.2 Orexo Business Overview
  28. 7.5.3 Orexo Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Orexo Digital Therapeutics Platforms for Mental Health Product Portfolio
  30. 7.5.5 Orexo Recent Developments
  31. 7.6 SilverCloud (Amwell)
  32. 7.6.1 SilverCloud (Amwell) Company Information
  33. 7.6.2 SilverCloud (Amwell) Business Overview
  34. 7.6.3 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Product Portfolio
  36. 7.6.5 SilverCloud (Amwell) Recent Developments
  37. 7.7 Noom
  38. 7.7.1 Noom Company Information
  39. 7.7.2 Noom Business Overview
  40. 7.7.3 Noom Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Noom Digital Therapeutics Platforms for Mental Health Product Portfolio
  42. 7.7.5 Noom Recent Developments
  43. 7.8 Big Health
  44. 7.8.1 Big Health Company Information
  45. 7.8.2 Big Health Business Overview
  46. 7.8.3 Big Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Big Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  48. 7.8.5 Big Health Recent Developments
  49. 7.9 Cognoa
  50. 7.9.1 Cognoa Company Information
  51. 7.9.2 Cognoa Business Overview
  52. 7.9.3 Cognoa Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cognoa Digital Therapeutics Platforms for Mental Health Product Portfolio
  54. 7.9.5 Cognoa Recent Developments
  55. 7.10 Headspace Health
  56. 7.10.1 Headspace Health Company Information
  57. 7.10.2 Headspace Health Business Overview
  58. 7.10.3 Headspace Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Headspace Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  60. 7.10.5 Headspace Health Recent Developments
  61. 7.11 Calm Health
  62. 7.11.1 Calm Health Company Information
  63. 7.11.2 Calm Health Business Overview
  64. 7.11.3 Calm Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Calm Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  66. 7.11.5 Calm Health Recent Developments
  67. 7.12 Lark Health
  68. 7.12.1 Lark Health Company Information
  69. 7.12.2 Lark Health Business Overview
  70. 7.12.3 Lark Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lark Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  72. 7.12.5 Lark Health Recent Developments
  73. 7.13 Vida Health
  74. 7.13.1 Vida Health Company Information
  75. 7.13.2 Vida Health Business Overview
  76. 7.13.3 Vida Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vida Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  78. 7.13.5 Vida Health Recent Developments
  79. 7.14 Mahana Therapeutics
  80. 7.14.1 Mahana Therapeutics Company Information
  81. 7.14.2 Mahana Therapeutics Business Overview
  82. 7.14.3 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio
  84. 7.14.5 Mahana Therapeutics Recent Developments
  85. 7.15 Blue Note Therapeutics
  86. 7.15.1 Blue Note Therapeutics Company Information
  87. 7.15.2 Blue Note Therapeutics Business Overview
  88. 7.15.3 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio
  90. 7.15.5 Blue Note Therapeutics Recent Developments
  91. 7.16 Lyra Health
  92. 7.16.1 Lyra Health Company Information
  93. 7.16.2 Lyra Health Business Overview
  94. 7.16.3 Lyra Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Lyra Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  96. 7.16.5 Lyra Health Recent Developments
  97. 7.17 Modern Health
  98. 7.17.1 Modern Health Company Information
  99. 7.17.2 Modern Health Business Overview
  100. 7.17.3 Modern Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Modern Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  102. 7.17.5 Modern Health Recent Developments
  103. 7.18 Canary Health
  104. 7.18.1 Canary Health Company Information
  105. 7.18.2 Canary Health Business Overview
  106. 7.18.3 Canary Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Canary Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  108. 7.18.5 Canary Health Recent Developments
  109. 7.19 Woebot Health
  110. 7.19.1 Woebot Health Company Information
  111. 7.19.2 Woebot Health Business Overview
  112. 7.19.3 Woebot Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Woebot Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  114. 7.19.5 Woebot Health Recent Developments
  115. 7.20 LifeStance Health
  116. 7.20.1 LifeStance Health Company Information
  117. 7.20.2 LifeStance Health Business Overview
  118. 7.20.3 LifeStance Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  119. 7.20.4 LifeStance Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  120. 7.20.5 LifeStance Health Recent Developments
  121. 7.21 Cerebral
  122. 7.21.1 Cerebral Company Information
  123. 7.21.2 Cerebral Business Overview
  124. 7.21.3 Cerebral Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Cerebral Digital Therapeutics Platforms for Mental Health Product Portfolio
  126. 7.21.5 Cerebral Recent Developments
  127. 7.22 MoodMission
  128. 7.22.1 MoodMission Company Information
  129. 7.22.2 MoodMission Business Overview
  130. 7.22.3 MoodMission Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  131. 7.22.4 MoodMission Digital Therapeutics Platforms for Mental Health Product Portfolio
  132. 7.22.5 MoodMission Recent Developments
  133. 7.23 Youper
  134. 7.23.1 Youper Company Information
  135. 7.23.2 Youper Business Overview
  136. 7.23.3 Youper Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Youper Digital Therapeutics Platforms for Mental Health Product Portfolio
  138. 7.23.5 Youper Recent Developments
  139. 7.24 Best Covered
  140. 7.24.1 Best Covered Company Information
  141. 7.24.2 Best Covered Business Overview
  142. 7.24.3 Best Covered Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Best Covered Digital Therapeutics Platforms for Mental Health Product Portfolio
  144. 7.24.5 Best Covered Recent Developments
  145. 7.25 Dami and Xiaomi
  146. 7.25.1 Dami and Xiaomi Company Information
  147. 7.25.2 Dami and Xiaomi Business Overview
  148. 7.25.3 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Product Portfolio
  150. 7.25.5 Dami and Xiaomi Recent Developments
  151. 7.26 WeiMai
  152. 7.26.1 WeiMai Company Information
  153. 7.26.2 WeiMai Business Overview
  154. 7.26.3 WeiMai Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  155. 7.26.4 WeiMai Digital Therapeutics Platforms for Mental Health Product Portfolio
  156. 7.26.5 WeiMai Recent Developments
8 North America
  1. 8.1 North America Digital Therapeutics Platforms for Mental Health Revenue (2021-2032)
  2. 8.2 North America Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032)
  5. 8.3 North America Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032)
  9. 8.5 North America Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Therapeutics Platforms for Mental Health Revenue by Country
  11. 8.6.1 North America Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Therapeutics Platforms for Mental Health Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Therapeutics Platforms for Mental Health Revenue (2021-2032)
  2. 9.2 Europe Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Therapeutics Platforms for Mental Health Revenue by Country
  11. 9.6.1 Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Therapeutics Platforms for Mental Health Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Therapeutics Platforms for Mental Health Revenue (2021-2032)
  2. 10.2 China Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032)
  5. 10.3 China Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032)
  9. 10.5 China Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Therapeutics Platforms for Mental Health Revenue (2021-2032)
  2. 11.2 Asia Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Therapeutics Platforms for Mental Health Revenue by Country
  11. 11.6.1 Asia Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Therapeutics Platforms for Mental Health Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Therapeutics Platforms for Mental Health Revenue (2021-2032)
  2. 12.2 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Therapeutics Platforms for Mental Health Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Therapeutics Platforms for Mental Health Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country
  11. 12.6.1 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Therapeutics Platforms for Mental Health Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst